Ra Capital Management as of Sept. 30, 2014
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 43 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 15.4 | $131M | 5.3M | 24.77 | |
| Achillion Pharmaceuticals | 11.4 | $97M | 9.7M | 9.98 | |
| Dyax | 9.3 | $79M | 7.8M | 10.12 | |
| Sangamo Biosciences (SGMO) | 9.2 | $78M | 7.2M | 10.79 | |
| BioCryst Pharmaceuticals (BCRX) | 8.2 | $69M | 7.1M | 9.78 | |
| AVANIR Pharmaceuticals | 7.6 | $64M | 5.4M | 11.92 | |
| Sunesis Pharmaceuticals | 4.1 | $35M | 4.9M | 7.14 | |
| Dicerna Pharmaceuticals | 3.6 | $31M | 2.4M | 12.73 | |
| Bluebird Bio (BLUE) | 3.1 | $26M | 729k | 35.88 | |
| Ophthotech | 2.7 | $23M | 589k | 38.93 | |
| Zs Pharma | 2.6 | $22M | 565k | 39.23 | |
| Tg Therapeutics (TGTX) | 2.6 | $22M | 2.1M | 10.67 | |
| Novavax | 2.5 | $21M | 5.1M | 4.17 | |
| Dynavax Technologies Corporation | 2.1 | $17M | 12M | 1.43 | |
| Versartis | 2.0 | $17M | 899k | 18.99 | |
| Therapeuticsmd | 1.9 | $16M | 3.5M | 4.64 | |
| Zafgen | 1.7 | $14M | 733k | 19.65 | |
| Akebia Therapeutics (AKBA) | 1.6 | $13M | 597k | 22.13 | |
| Xencor (XNCR) | 1.4 | $12M | 1.2M | 9.31 | |
| Enanta Pharmaceuticals (ENTA) | 1.2 | $9.9M | 250k | 39.57 | |
| Tenax Therapeutics | 1.1 | $9.2M | 2.3M | 3.93 | |
| Scynexis | 0.7 | $6.2M | 840k | 7.39 | |
| Vical Incorporated | 0.7 | $6.1M | 5.5M | 1.12 | |
| Auris Med Hldg | 0.6 | $5.4M | 940k | 5.77 | |
| T2 Biosystems | 0.3 | $2.5M | 138k | 18.09 | |
| Wafergen Bio-systems | 0.3 | $2.4M | 560k | 4.35 | |
| Ocera Therapeutics | 0.2 | $2.0M | 418k | 4.90 | |
| Alimera Sciences | 0.2 | $1.3M | 244k | 5.42 | |
| Codexis (CDXS) | 0.1 | $1.2M | 504k | 2.33 | |
| Ptc Therapeutics I (PTCT) | 0.1 | $1.1M | 26k | 43.99 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $1.1M | 18k | 61.36 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.1 | $1.0M | 9.3k | 112.26 | |
| Merrimack Pharmaceuticals In | 0.1 | $1.0M | 116k | 8.78 | |
| Repligen Corporation (RGEN) | 0.1 | $896k | 45k | 19.91 | |
| Keryx Biopharmaceuticals | 0.1 | $814k | 59k | 13.75 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $883k | 2.5k | 360.41 | |
| Amgen (AMGN) | 0.1 | $829k | 5.9k | 140.51 | |
| Biogen Idec (BIIB) | 0.1 | $860k | 2.6k | 330.77 | |
| Celgene Corporation | 0.1 | $825k | 8.7k | 94.83 | |
| Alkermes (ALKS) | 0.1 | $823k | 19k | 42.86 | |
| Puma Biotechnology (PBYI) | 0.1 | $740k | 3.1k | 238.71 | |
| Kythera Biopharmaceuticals I | 0.1 | $745k | 23k | 32.75 | |
| Newlink Genetics Corporation | 0.1 | $643k | 30k | 21.43 |
